Dopaminergic psychosis in advanced Parkinson's disease.
Fischer
P
P
Neurological Institute, Vienna Medical School, Austria.
Danielczyk
W
W
Simanyi
M
M
Streifler
M B
MB
D000368:Aged; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006801:Humans; D008134:Long-Term Care; D008137:Longitudinal Studies; D010300:Parkinson Disease / Q000188:drug therapy*; D011605:Psychoses, Substance-Induced / Q000209:etiology*; D011954:Receptors, Dopamine / Q000187:drug effects*; D012307:Risk Factors
D000978:Antiparkinson Agents; D011954:Receptors, Dopamine